Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M107,746Revenue (TTM) $M37,751Net Margin (%)12.8Altman Z-Score2.0
Enterprise Value $M116,648EPS (TTM) $1.9Operating Margin %15.9Piotroski F-Score5
P/E(ttm)22.3Beneish M-Score-2.3Pre-tax Margin (%)14.7Higher ROA y-yN
Price/Book1.710-y EBITDA Growth Rate %6.3Quick Ratio1.4Cash flow > EarningsN
Price/Sales2.85-y EBITDA Growth Rate %-2.5Current Ratio1.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-9.8ROA % (ttm)7.3Higher Current Ratio y-yN
Dividend Yield %4.0PEG--ROE % (ttm)12.7Less Shares Outstanding y-yY
Payout Ratio %87.0Shares Outstanding M2,611ROIC % (ttm)12.3Gross Margin Increase y-yY

Gurus Latest Trades with SNY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SNYCharles Brandes 2016-03-31 Add0.78%$38.37 - $42.65
($40.17)
$ 41.263%Add 61.76%3,556,721
SNYDodge & Cox 2016-03-31 Add0.14%$38.37 - $42.65
($40.17)
$ 41.263%Add 7.24%53,530,129
SNYNWQ Managers 2016-03-31 Reduce-0.09%$38.37 - $42.65
($40.17)
$ 41.263%Reduce -6.34%1,946,427
SNYBill Nygren 2016-03-31 Reduce-0.05%$38.37 - $42.65
($40.17)
$ 41.263%Reduce -3.53%5,470,000
SNYBarrow, Hanley, Mewhinney & Strauss 2016-03-31 Reduce-0.03%$38.37 - $42.65
($40.17)
$ 41.263%Reduce -1.36%29,087,790
SNYJoel Greenblatt 2016-03-31 Buy 0.02%$38.37 - $42.65
($40.17)
$ 41.263%New holding34,720
SNYDavid Dreman 2016-03-31 Buy 0.01%$38.37 - $42.65
($40.17)
$ 41.263%New holding1,870
SNYKen Fisher 2016-03-31 Add0.01%$38.37 - $42.65
($40.17)
$ 41.263%Add 0.97%13,546,950
SNYHOTCHKIS & WILEY 2016-03-31 Add$38.37 - $42.65
($40.17)
$ 41.263%Add 0.23%10,164,994
SNYMario Gabelli 2016-03-31 Sold Out $38.37 - $42.65
($40.17)
$ 41.263%Sold Out0
SNYNWQ Managers 2015-12-31 Reduce-0.31%$41.51 - $51.49
($45.91)
$ 41.26-10%Reduce -16.94%2,078,119
SNYHOTCHKIS & WILEY 2015-12-31 Add0.19%$41.51 - $51.49
($45.91)
$ 41.26-10%Add 12.24%10,141,383
SNYCharles Brandes 2015-12-31 Reduce-0.06%$41.51 - $51.49
($45.91)
$ 41.26-10%Reduce -3.98%2,198,827
SNYBarrow, Hanley, Mewhinney & Strauss 2015-12-31 Add0.02%$41.51 - $51.49
($45.91)
$ 41.26-10%Add 1.26%29,489,368
SNYKen Fisher 2015-12-31 Add0.01%$41.51 - $51.49
($45.98)
$ 41.26-10%Add 0.90%13,416,220
SNYDavid Dreman 2015-12-31 Sold Out -0.01%$41.51 - $51.49
($45.91)
$ 41.26-10%Sold Out0
SNYDodge & Cox 2015-12-31 Add$41.51 - $51.49
($45.91)
$ 41.26-10%Add 0.11%49,915,073
SNYHOTCHKIS & WILEY 2015-09-30 Reduce-0.29%$46.64 - $54.98
($50.92)
$ 41.26-19%Reduce -15.57%9,035,695
SNYCharles Brandes 2015-09-30 Reduce-0.17%$46.64 - $54.98
($50.92)
$ 41.26-19%Reduce -10.56%2,290,031
SNYNWQ Managers 2015-09-30 Reduce-0.09%$46.64 - $54.98
($50.92)
$ 41.26-19%Reduce -5.10%2,501,826
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SNY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SNY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sanofi10% Owner 2015-01-29Buy97,118$95-56.57view
Sanofi10% Owner 2015-01-26Buy647,448$95-56.57view
Sanofi10% Owner 2015-01-22Buy196,251$93.17-55.72view
Sanofi10% Owner 2014-03-25Buy344,448$66.88-38.31view
Sanofi10% Owner 2014-02-04Buy1,303,780$7.67437.94view

Press Releases about SNY :

Quarterly/Annual Reports about SNY:

    News about SNY:

    Articles On GuruFocus.com
    Endonovo Therapeutics: Innovative Treatment, Catalyst Create Compelling Opportunity May 22 2016 
    Charles Brandes Trims Stake in South American Petroleum Company May 13 2016 
    Warren Buffett’s Top 5 Dividend Yielding Stocks Apr 26 2016 
    Manning & Napier Sells Chunks of Stakes in GE, Eli Lilly, Merck Mar 29 2016 
    Amgen: Should I Just Sit and Wait? Mar 18 2016 
    Sanofi's New Products Will Fuel Sales Mar 13 2016 
    Warren Buffett's Worst Performing Stocks Mar 03 2016 
    Dodge & Cox Global Stock Fund 4th Quarter Commentary Jan 19 2016 
    Dodge & Cox Stock Fund 2015 Commentary Jan 18 2016 
    Why MannKind Could Be a Value Trap Jan 04 2016 

    More From Other Websites
    [$$] Medivation’s Sanofi Strategy May Be in Trouble May 27 2016
    [$$] Medivation May Feel Pressured by Sanofi May 27 2016
    Dealpolitik: Medivation's 'Just Say No' Strategy May Be in Trouble May 27 2016
    Medivation Fires Back Following Sanofi's Board Proposal May 27 2016
    How Medivation Shareholders May Lose Big by Poison Pill in Hostile Takeover Fight With Sanofi May 26 2016
    Sanofi's Diabetes Drug Combination Wins FDA Panel Backing May 26 2016
    2:44 am Sanofi receives FDA recommendation of NDA for treatment for adults with Type 2 diabetes May 26 2016
    [$$] Sanofi Moves to Replace Medivation Board May 25 2016
    FDA Advisory Committee Recommends Approval of Sanofi Treatment for Adults with Type 2 Diabetes May 25 2016
    Medivation: Three Biotech Giants Enter. Which One Leaves? May 25 2016
    Stocks climb for the second day as energy companies jump May 25 2016
    Sanofi moves to oust Medivation board in $9.3 billion takeover fight May 25 2016
    Sanofi moves to oust Medivation board in $9.3 billion takeover fight May 25 2016
    Sanofi moves to oust Medivation board in $9.3 bln takeover fight May 25 2016
    U.S. panel backs approval of Sanofi combination diabetes drug May 25 2016
    Sanofi Moves To Replace Medivation’s Board As New Buyers Rumored May 25 2016
    Alnylam Soars as Drugmakers Circle Rival Biotechnology Company May 25 2016
    [$$] Sanofi Moves to Replace Medivation Board May 25 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)